title: In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy.
abstract: Distribution of protein zero (P0) and myelin basic protein (MBP) mRNAs in the sciatic nerve from rats with alloxan-induced diabetes was analyzed at two different time points using in situ hybridization. Some animals of each diabetic group were treated with insulin. Densitometric quantitation of silver clusters revealed that 5 weeks after diabetes induction P0 mRNA only is significantly increased, while at 14 weeks both P0 and MBP mRNA contents are markedly higher than controls. Insulin treatment normalizes glycemia levels and slightly counteracts increased P0 mRNA at both stages of diabetes. An increase in MBP mRNA is observed in chronic diabetic animals only, and is unaltered by the normoglycemic effect of insulin. The increased transcript levels of P0 and MBP suggest that Schwann cells can modulate gene expression of myelin-specific proteins in response to diabetic-induced metabolic derangement. Such a change may represent a higher turnover of myelin proteins as an attempt by the Schwann cells to repair the diabetes-induced nerve damage. The observed pattern of transcript amount is only slightly influenced by insulin treatment.
authors.affiliation: Institute of Neurology, Dino Ferrari Center, University of Milan, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Conti
authors.forename: E
authors.initials: E
authors.lastname: Scarpini
authors.forename: M L
authors.initials: ML
authors.lastname: Malosio
authors.forename: A M
authors.initials: AM
authors.lastname: Di Giulio
authors.forename: P
authors.initials: P
authors.lastname: Baron
authors.forename: G
authors.initials: G
authors.lastname: Scarlato
authors.forename: P
authors.initials: P
authors.lastname: Mantegazza
authors.forename: A
authors.initials: A
authors.lastname: Gorio
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism* / Q000628:therapy; D017403:In Situ Hybridization; D007328:Insulin / Q000627:therapeutic use; D004676:Myelin Basic Protein / Q000032:analysis* / Q000235:genetics; D018993:Myelin P0 Protein / Q000032:analysis* / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D012584:Sciatic Nerve / Q000378:metabolism*; D013997:Time Factors
chemical_list: D007328:Insulin; D004676:Myelin Basic Protein; D018993:Myelin P0 Protein; D012333:RNA, Messenger